Zhang Junge 4

What Happened Zhang Junge, a director of Ocugen, exercised stock options on April 1, 2026, acquiring a total of 194,134 shares. The exercises broke down as: 15,000 shares at $0.51 ($7,650), 112,205 shares at $0.46 ($51,614), and 66,929 shares at $1.42 ($95,039), for an aggregate cash cost of approximately $154,303. Each exercise is reported with transaction code "M" (exercise/conversion of a derivative). The filing also shows corresponding disposals at $0.00 for the same share amounts, which reflect the conversion/termination of the underlying option interests upon exercise rather than market sales.

Key Details

• Transaction date: April 1, 2026; Form 4 filed April 2, 2026 (within the typical 2-business-day window).
• Individual transactions:
  • 15,000 shares exercised at $0.51 — $7,650 (Footnote F1).
  • 112,205 shares exercised at $0.46 — $51,614 (Footnote F2).
  • 66,929 shares exercised at $1.42 — $95,039 (Footnote F3).
• Aggregate: 194,134 shares acquired for ~$154,303.
• Shares owned after transaction: Not specified in the provided filing details.
• Footnotes:
  • F1: Option (originally for 54,000 shares) vested in equal installments beginning Jan 2, 2020.
  • F2: Option for 112,205 shares vested and became exercisable on June 9, 2024.
  • F3: Option for 66,929 shares vested and became exercisable on June 28, 2025.
• Transaction code: M = exercise/conversion of derivative. Disposals at $0 reflect termination/conversion of the derivative, not a sale.

Context This was an options exercise (insider paid to convert options into common shares). The filing shows no immediate open-market sale of the acquired shares (no cashless sale reported), and there’s no indication of a 10b5-1 plan or gift. Exercises are common for insiders managing vested equity and do not, by themselves, signal a specific change in view on the company.